Differences between revisions 3 and 4
Revision 3 as of 2013-07-02 03:50:26
Size: 10171
Editor: jbarhak
Comment:
Revision 4 as of 2013-07-02 03:53:29
Size: 10489
Editor: jbarhak
Comment:
Deletions are marked like this. Additions are marked like this.
Line 75: Line 75:
Line 76: Line 77:
Line 77: Line 79:
Line 78: Line 81:
Line 79: Line 83:
Line 80: Line 85:
Line 81: Line 87:
Line 82: Line 89:
Line 83: Line 91:
Line 84: Line 93:
Line 85: Line 95:
Line 86: Line 97:
Line 90: Line 102:
Line 94: Line 107:
Line 95: Line 109:
Line 96: Line 111:
Line 97: Line 113:
Line 101: Line 118:
Line 102: Line 120:
Line 103: Line 122:
Line 104: Line 124:
Line 105: Line 126:
Line 106: Line 128:
Line 107: Line 130:
Line 108: Line 132:
Line 109: Line 134:
Line 110: Line 136:
Line 111: Line 138:
Line 114: Line 142:
Line 119: Line 148:
Line 120: Line 150:
Line 121: Line 152:
Line 122: Line 154:
Line 123: Line 156:
Line 126: Line 160:
Line 127: Line 162:
Line 128: Line 164:
Line 129: Line 166:
Line 130: Line 168:
Line 134: Line 173:
Line 135: Line 175:
Line 136: Line 177:
Line 137: Line 179:
Line 138: Line 181:
Line 139: Line 183:
Line 140: Line 185:
Line 141: Line 187:
Line 142: Line 189:
Line 143: Line 191:
Line 146: Line 195:

Line 155: Line 206:

Line 161: Line 214:
Line 162: Line 216:
Line 163: Line 218:
Line 164: Line 220:
Line 165: Line 222:
Line 166: Line 224:
Line 167: Line 226:
Line 168: Line 228:
Line 169: Line 230:
Line 170: Line 232:
Line 175: Line 238:
Line 176: Line 240:
Line 177: Line 242:
Line 178: Line 244:
Line 179: Line 246:
Line 180: Line 248:
Line 181: Line 250:
Line 185: Line 255:
Line 186: Line 257:
Line 187: Line 259:
Line 188: Line 261:
Line 189: Line 263:
Line 190: Line 265:
Line 191: Line 267:
Line 194: Line 271:
Line 195: Line 273:
Line 196: Line 275:
Line 197: Line 277:
Line 198: Line 279:
Line 199: Line 281:
Line 200: Line 283:
Line 201: Line 285:
Line 202: Line 287:
Line 203: Line 289:
Line 205: Line 292:
Line 206: Line 294:
Line 207: Line 296:
Line 208: Line 298:
Line 209: Line 300:
Line 210: Line 302:
Line 211: Line 304:
Line 212: Line 306:
Line 213: Line 308:
Line 214: Line 310:
Line 215: Line 312:
Line 216: Line 314:
Line 217: Line 316:
Line 219: Line 319:

Line 220: Line 322:
Line 221: Line 324:
Line 222: Line 326:
Line 223: Line 328:
Line 224: Line 330:
Line 225: Line 332:
Line 226: Line 334:
Line 227: Line 336:
Line 229: Line 339:
Line 230: Line 341:
Line 231: Line 343:
Line 232: Line 345:
Line 233: Line 347:
Line 234: Line 349:
Line 237: Line 353:

Line 238: Line 356:
Line 239: Line 358:
Line 240: Line 360:
Line 241: Line 362:
Line 242: Line 364:
Line 244: Line 367:
Line 245: Line 369:
Line 246: Line 371:
Line 247: Line 373:
Line 248: Line 375:
Line 249: Line 377:
Line 250: Line 379:
Line 251: Line 381:
Line 252: Line 383:
Line 253: Line 385:
Line 254: Line 387:
Line 255: Line 389:
Line 256: Line 391:
Line 257: Line 393:
Line 258: Line 395:
Line 259: Line 397:
Line 260: Line 399:
Line 261: Line 401:
Line 262: Line 403:
Line 263: Line 405:
Line 264: Line 407:
Line 265: Line 409:
Line 266: Line 411:
Line 267: Line 413:
Line 268: Line 415:
Line 269: Line 417:
Line 270: Line 419:
Line 273: Line 423:
Line 277: Line 428:
Line 278: Line 430:
Line 279: Line 432:
Line 280: Line 434:
Line 282: Line 437:

Line 283: Line 440:
Line 284: Line 442:

Committee Presentation

This page will contain the up to date committee presentation. Discussions regarding the page can be found at the bottom of the page.

Committee on Credible Practice of Modeling & Simulation in Healthcare

prepared by

Committee Co-Chairs

Interagency Modeling and Analysis Group

Multiscale Modeling Consortium

April 12, 2013

https://simtk.org/home/cpms

DEFINITIONS

Credible Practice of Modeling & Simulation in Healthcare

dependable with a desired certainty level to guide research or support decision making within a prescribed application domain and intended use; establishing reproducibility & accountability

DEFINITIONS

Credible Practice of Modeling & Simulation in Healthcare

any activity involving development, solution, interpretation and application of computational representation of biological, environmental and man-made systems and their interaction thereof

DEFINITIONS

Credible Practice of Modeling & Simulation in Healthcare

specifically computational modeling; virtual representation of system(s) of interest in a usable form in order to provide descriptive and predictive metrics for timely and systematic exploration of the system(s)

DEFINITIONS

Credible Practice of Modeling & Simulation in Healthcare

computational solution of models to quantify descriptive and predictive metrics of system(s) of interest; including related post-processing efforts to calculate these metrics from raw analysis results

DEFINITIONS

Credible Practice of Modeling & Simulation in Healthcare

any activity involving development, maintenance, advancement, or administration of medical care; including research, diagnosis, risk assessment, prevention, therapy, rehabilitation, surgery, intervention design, and regulation

NEED

* Clinical urgency

- There is a pressing need to utilize computational modeling & simulation to support clinical research and decision making in healthcare.

- There is a gap in mechanisms or processes for translating computational models to the clinical practice.

* Research diversity

- Within and across mathematical and biological disciplines, subject matter experts tend to have their own interpretation of credibility assessment.

- Tools and good practice recommendations do not readily transfer across disciplines or are not adopted by different fields.

NEED

* Challenges of multiscale analysis

- Multiscale simulations require re-use of subsidiary models, which may have varying (or unknown) credibility.

- Propagation of uncertainties of a given scale for multiscale analysis can be complicated.

* Scattered activities

- In modeling & simulation (M&S) world, a plethora of commendable yet unconnected scientific and community activities exist for

- verification & validation

- uncertainty estimation

- error propagation

- evidence based assessment

- reporting recommendations

- model exchange and dissemination

- standards and mark-up development

- documentation

NEED

None of us are experts in everything. We need to learn from each other. Credible practice of modeling and simulation in healthcare requires ongoing inclusive communications to establish adaptive workflows that can be utilized broadly.

CHARGE

* Adopt a consistent terminology

* Propose guidelines and procedures for credible practice

* Demonstrate workflows for credible practice

* Promote good practice

CHARGE

Adopt a consistent terminology

* Clearly describe committee's understanding of modeling and simulation vocabulary, e.g.,

- model

- simulation

- multiscale

- verification

- validation

- uncertainty

- sensitivity

- credibility

- accreditation

* Consistently use appropriate vocabulary for communication

* Unify discipline-specific appreciation of modeling and simulation vocabulary

Propose guidelines and procedures for credible practice

* Identify translational research directions to leverage readily available techniques to increase credibility of modeling and simulation in healthcare, e.g.,

- verification and validation

- uncertainty quantification

? Establish guidelines to implement readily available model evaluation techniques which are aware of the constraints of clinical practice

? Define novel translational workflows to enhance credibility of models and simulation processes

CHARGE

Demonstrate workflows for credible practice

* Summarize state-of-the-art by identifying examples in literature and in field practice for the development of model credibility assessment procedures

* Conduct studies, ideally with proposed guidelines and procedures, for the implementation of credibility assessment procedures in modeling and simulation in healthcare

* Disseminate examples of credibility assessment by providing a repository of case studies on the implementation of proposed guidelines and procedures for different types of M&S

CHARGE

Promote good practice

* Bridge synergistic activities of establishing confidence in simulation-based medicine conducted by

- modeling and simulation communities

- scientific societies

- clinical practitioners

- regulatory agencies

* Outreach to advocate credible practice of modeling and simulation through increased awareness and training; by providing

- webinars

- lectures

- guidelines

ORGANIZATION

COMMITTEE Co-Chairs & Members: EXECUTE & CHARGE

ADVISORY COUNCIL: REVIEW & ADVISE

Interagency Modeling and Analysis Group (IMAG)

Multiscale Modeling Consortium (MSM)

ACTIVITY CYCLE: *** TBD IMAGE should go here

ROLES & EXPECTATIONS

Committee Co-Chairs (2)

* Provide leadership and guidance to the Committee

* Assign tasks to Committee Members to realize charge of the Committee and incorporate their work to reach Committee end-products

- Serve as Committee Members, i.e., take on and fulfill assigned tasks to realize charge of the Committee

- Report to Advisory Council and implement their feedback

- Report to IMAG/MSM and implement their feedback

- Evaluate performance of Committee Members

- Evaluate performance of Advisory Council

- Share authority and responsibilities equally

ROLES & EXPECTATIONS

* Committee Members (10 including Co-Chairs)

- Complete assigned tasks (on schedule) to realize charge of the Committee and prepare Committee end-products

- Report to the Committee and implement their feedback

- Represent a particular discipline and an area of practice to diversify Committee interests and reach out

- Evaluate performance of Committee Co-Chairs

- Evaluate performance of Advisory Council

- Expect to invest 8 hours of effort per month

ROLES & EXPECTATIONS

* Advisory Council

- Review Committee activities (on schedule) and provide feedback on the pathway for realization of the charge of the Committee and for preparation of Committee end-products

- Represent a particular discipline and an area of practice to broaden Committee affairs and reach out

- Evaluate performance of Committee Co-Chairs

- Evaluate performance of Committee Members

- Expect to invest 1 hour of effort per month

PARTICIPATION

Committee Co-Chairs (2)

* Nominated and elected by the Committee Members and the Advisory Council

* 2 year term with possibility of reappointment

* Elections 6 months prior to end of term

* Continuing post subject to commitment to leadership

* Ideally, one from IMAG and the other from MSM

* First-term (04/2013- 04/2015) appointed via IMAG consensus

- Lealem Mulugeta (NASA, IMAG representative)

- Ahmet Erdemir (Cleveland Clinic, MSM-WG representative)

PARTICIPATION

Committee Members (10 including Co-Chairs)

* Participation through nomination and invitation

* 2 year term with possibility of reappointment

* Continuing membership subject to commitment to timely completion of tasks

* Multidisciplinary background

- clinicians

- mathematicians

- biologists

- engineers

- statisticians

- computer scientists

- product developers

PARTICIPATION

Committee Members (10 including Co-Chairs)

* Wide variety of groups

- IMAG representatives

- MSM working groups

- External representatives

- Professional Societies

- Regulatory Agencies

- Funding Agencies

PARTICIPATION

Advisory Council

* Participation through nomination and invitation

- 2 year term with possibility of reappointment

- Continuing membership subject to commitment to providing feedback in a timely manner

- Substantial experience and expertise in respective areas of interest

FIRST-TERM (2013-2015) GOALS

* Form the Committee and the Advisory Council

* Establish infrastructure for communications between Committee Co-Chairs and Members, and Advisory Council

* Establish a web-based framework for development, community interactions, and dissemination

* Develop a guidance document on establishing credible practice of modeling and simulation in healthcare

* Draft a proposed model certification process

FIRST-TERM (2013-2015) TIMELINE

by April 30, 2013

* Establish communication infrastructure

* Establish web-based framework

* Appoint Committee Members

* Introductory meeting with Committee Members

* Discuss objectives, roles & assign tasks

by May 31, 2013

* Meeting with Committee Member to review first set of tasks

* Appoint Advisory Council

* Introductory meeting with Advisory Council

* Discuss objectives, roles & summarize progress

by June 30, 2013

* Working outline of guidance document

by MSM 2013 meeting

* Community outreach to summarize progress and plans

by April 30, 2014

* First draft of guidance document for external review

by October 31, 2014

* Release of guidance document

by November 30, 2014

* Journal article/white paper based on guidance document

* Outline of model certification process

* Co-Chairs; nominations and election

through December 2014 – April 2015

* Co-Chairs; transition

* First draft of proposed model certification process

CONTACT

CHECK https://simtk.org/home/cpms

Lealem Mulugeta

Committee Co-Chair

mulugeta@dsls.usra.edu

lealem.mulugeta@nasa.gov

Ahmet Erdemir

Committee Co-Chair

erdemira@ccf.org

Committee Presentation (last edited 2016-05-04 22:03:12 by localhost)